Idex Corporation · NYSE:IEX

Idex — Q1 2018 Earnings Presentation

9 slides from Idex's earnings presentation, Apr 30, 2018

  1. Slide 1: First Quarter 2018 Earnings

    First Quarter 2018 Earnings April 30, 2018 IDEX Proprietary & Confidential

  2. Slide 2: Agenda

    AGENDA • IDEX’s Overview and Outlook • Q1 Financial Performance • Segment Performance • Fluid & Metering Technologies • Health & Science Technologies • Fire & Safety / Diversified Products • 2018 Guidance Summary • Q&A Brand names shown in this presentation are registered trademarks of IDEX Corporat

  3. Slide 3: Replay Information

    Replay Information • Dial toll–free: 877.660.6853 • International: 201.612.7415 • Conference ID: #13675419 • Log on to: www.idexcorp.com Brand names shown in this presentation are registered trademarks of IDEX Corporation and/or its subsidiaries IDEX Proprietary & Confidential 2

  4. Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures

    Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation and discussion will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other thin

  5. Slide 5: IDEX Q1 Financial Performance

    IDEX Q1 Financial Performance (Dollars in millions, excl. EPS) Sales Adjusted EPS* 25% increase Organic: 7% increase $1.29 $1.03 $612 $554 $1.50 $700 $1.00 $500 $0.50 $300 $0.00 Q1 Q1 2017 2018 2017 2018 Adjusted Operating Margin* Free Cash Flow 80 bps increase 18% decrease 22.6% 21.8% $75 $100 $62

  6. Slide 6: Fluid & Metering Technologies

    Fluid & Metering Technologies (Dollars in millions) Orders Sales Adjusted Operating Margin* Organic: 7% increase Organic: 5% increase 110 bps increase $238 $217 $232 $219 $300 28.5% $300 30.0% 27.4% $200 $200 28.0% $100 $100 26.0% $0 $0 24.0% Q1 Q1 Q1 2017 2018 2017 2018 2017 2018 Q1 Sales Mix: Orga

  7. Slide 7: Health & Science Technologies

    Health & Science Technologies (Dollars in millions) Orders Sales Adjusted Operating Margin* Organic: 8% increase Organic: 6% increase 120 bps increase $240 23.9% $211 $221 22.7% $250 $200 24.0% $250 $200 $200 22.0% $150 $150 20.0% $100 $100 18.0% Q1 Q1 Q1 2017 2018 2017 2018 2017 2018 Q1 Sales Mix:

  8. Slide 8: Fire & Safety / Diversified Products

    Fire & Safety / Diversified Products (Dollars in millions) Orders Sales Adjusted Operating Margin* 110 bps increase Organic: 5% increase Organic: 9% increase 24.9% $159 26.0% 23.8% $154 $200 $200 $139 $137 24.0% $150 $150 22.0% $100 $100 20.0% $50 $50 Q1 Q1 Q1 2017 2018 2017 2018 2017 2018 Q1 Sales

  9. Slide 9: 2018 Guidance Summary

    2018 Guidance Summary Q2 2018 – EPS estimate range: $1.30 – $1.32 – Organic revenue growth: 5 – 6% – Operating margin: ~ 22.5% – Tax rate: ~ 22.5% – FX impact: ~ 3.0% topline tailwind based on March 31, 2018 FX rates – Corporate costs: ~ $20 million FY 2018 – EPS estimate range: $5.05 – $5.20 – Orga

IDEX — Q1 2018 Earnings Presentation on 6ix